Imaging Techniques for Diagnosing Gastric Cancer
Energy CT in Imaging and Diagnosis of Gastric Cancer
Recruiting
Observational Study
Gastric Cancer
CT
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 300 (estimated)
- Sponsor
- The First Affiliated Hospital of Zhengzhou University · Other
Who this trial is looking for
This trial is looking for patients with gastric cancer to study new imaging techniques that may help in diagnosis and treatment planning. Participants will have imaging tests as part of their care.
Are You a Good Fit for This Trial?
You may be able to join if
- I have been diagnosed with gastric cancer
- I am having surgery to remove my stomach cancer
You may not be able to join if
- I cannot sign the consent form
- My imaging tests are of poor quality
- I have other cancers and serious organ problems
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Accurate preoperative prediction of risk stratification, treatment response, and survival prognosis in gastric cancer is important for improving clinical treatment decisions, prolonging patient survival, and improving patient quality of life. The purpose of this study is to investigate the performance of the multi-parametric magnetic resonance imaging (mpMRI) and Dual-/Muti-energy CT and photon-co…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Pathological biopsy confirmed gastric cancer;
2. Surgery: patients undergoing radical gastrectomy. Patients undergoing exploratory abdominal surgery or palliative tumor resection were still included in the study when peritoneal metastasis or adjacent organ invasion was identi…
Contacts